These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1502606)

  • 1. Estrogen therapy for geriatric osteoporosis: just one ball in a complex juggling act.
    Hillner BE
    South Med J; 1992 Aug; 85(8):2S10-6. PubMed ID: 1502606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective.
    Orwoll ES; Nelson HD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1872-4. PubMed ID: 10372678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis].
    Urano T
    Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to estrogen replacement therapy.
    Rosen CJ; Kessenich CR
    Endocrinol Metab Clin North Am; 1997 Jun; 26(2):295-311. PubMed ID: 9193885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing osteoporosis in symptomatic postmenopausal women.
    Gallagher JC; Levine JP
    Menopause; 2011 Jan; 18(1):109-18. PubMed ID: 20661164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risks and benefits of estrogen replacement therapy: Leisure World.
    Paganini-Hill A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogens for treatment of osteoporoses].
    Higuchi T; Tarakida A; Abe K; Mizunuma H
    Nihon Rinsho; 2009 May; 67(5):954-9. PubMed ID: 19432116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits and risks of hormone replacement therapy: an epidemiologic overview.
    Harlap S
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1986-92. PubMed ID: 1605289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phytoestrogens--an alternative to hormonal replacement therapy].
    Drosdzol A; Skrzypulec V; Nowosielski K; Piela B; Rozmus-Warcholińska W; Walaszek A
    Wiad Lek; 2004; 57 Suppl 1():74-7. PubMed ID: 15884209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risks and benefits of long-term estrogen replacement therapy.
    Barrett-Connor EL
    Public Health Rep; 1989; 104 Suppl(Suppl):62-5. PubMed ID: 2517703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen replacement therapy: indications, contraindications, and agent selection.
    Notelovitz M
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 2):1832-41. PubMed ID: 2690635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.